isradipine has been researched along with Cardiovascular Stroke in 3 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of the present paper is to formulate nanostructured lipid carriers (NLCs) of a calcium channel blocker, isradipine, to enhance its oral bioavailability and prolong its antihypertensive effect apart from evaluating efficacy of the formulation in isoproterenol induced myocardial infarction in rats." | 8.12 | Nanostructured lipid carriers of isradipine for effective management of hypertension and isoproterenol induced myocardial infarction. ( Alam, T; Ali, J; Ansari, MA; Baboota, S, 2022) |
| "The calcium-entry blocker isradipine was tested in a closed-chest pig model for chronic myocardial infarction." | 7.68 | Effects of isradipine on hemodynamic parameters and ventricular tachycardia in healed myocardial infarction. ( de Langen, CD; Lie, KI; Tio, RA; van den Toren, EW; Wesseling, H, 1990) |
| "The objective of the present paper is to formulate nanostructured lipid carriers (NLCs) of a calcium channel blocker, isradipine, to enhance its oral bioavailability and prolong its antihypertensive effect apart from evaluating efficacy of the formulation in isoproterenol induced myocardial infarction in rats." | 4.12 | Nanostructured lipid carriers of isradipine for effective management of hypertension and isoproterenol induced myocardial infarction. ( Alam, T; Ali, J; Ansari, MA; Baboota, S, 2022) |
| "Myocytes isolated from rat hearts that have suffered 35% myocardial infarction (MI) 3 wk prior have lower peak cytosolic Ca2+ concentration ([Ca2+]i) during contraction compared with Sham myocytes, a difference that is amplified by isoproterenol or high extracellular Ca2+ concentration ([Ca2+]o)." | 3.69 | Calcium currents in postinfarction rat cardiac myocytes. ( Cheung, JY; Moore, RL; Tillotson, DL; Zhang, XQ, 1995) |
| "The calcium-entry blocker isradipine was tested in a closed-chest pig model for chronic myocardial infarction." | 3.68 | Effects of isradipine on hemodynamic parameters and ventricular tachycardia in healed myocardial infarction. ( de Langen, CD; Lie, KI; Tio, RA; van den Toren, EW; Wesseling, H, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Alam, T | 1 |
| Ansari, MA | 1 |
| Baboota, S | 1 |
| Ali, J | 1 |
| Zhang, XQ | 1 |
| Moore, RL | 1 |
| Tillotson, DL | 1 |
| Cheung, JY | 1 |
| de Langen, CD | 1 |
| van den Toren, EW | 1 |
| Tio, RA | 1 |
| Lie, KI | 1 |
| Wesseling, H | 1 |
3 other studies available for isradipine and Cardiovascular Stroke
| Article | Year |
|---|---|
Nanostructured lipid carriers of isradipine for effective management of hypertension and isoproterenol induced myocardial infarction.
Topics: Administration, Oral; Animals; Antioxidants; Drug Carriers; Hypertension; Isoproterenol; Isradipine; | 2022 |
Calcium currents in postinfarction rat cardiac myocytes.
Topics: Animals; Calcium; Dihydropyridines; Electric Conductivity; Heart; Isoproterenol; Isradipine; Male; M | 1995 |
Effects of isradipine on hemodynamic parameters and ventricular tachycardia in healed myocardial infarction.
Topics: Animals; Calcium Channel Blockers; Creatine Kinase; Electric Stimulation; Electrocardiography; Hemod | 1990 |